Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

False · Brier 0.25

Rules 1.1.0 · as of 14 Sep 2026

Quote

“Eventually, in a post-prohibition world, there could be a licensed regulatory system for adults to legally access psychedelics to take on their own without supervision by therapists with access to minors only with permission from their parents or guardians.”
· From the Desk of Rick Doblin, Ph.D. – Autumn 2020 · own post

Autumn 2020 column. Long-term drug-policy vision of licensed adult access to psychedelics.

Intake

EventA proposition written from a template on the asset, with a resolution criterion and a named public source, before the outcome is looked up. The same event resolves every person's items on it. Method ›
A US licence lets adults legally buy psychedelics for unsupervised personal use
AreaOne of five topic classes: regulatory decisions, clinical trial outcomes, company and market outcomes, payer and policy, practice adoption. Every event has one area. Method ›
Payer and policy
DeadlineThe date by which the event must happen for the item to be true. It comes only from the person's words through the anchor table. Method ›
None stated · undated panelItems with no deadline in the person's words, scored on a uniform 24-month window from the statement date. Part of the headline panel since rules 1.1.0; also shown on its own. Method ›, 24-month window to 13 Dec 2022
Probability
0.50 LexiconThe fixed five-bin table that turns a phrase into a probability. The strongest phrase in the claim sentence decides; coders never read tone. Method › · binOne of five lexicon steps: A 'will' 0.90, B 'probably' 0.70, C 'may' 0.50, D 'unlikely' 0.30, E 'never' 0.10. A stated number goes to the nearest bin for calibration only. Method › C · “there could be a licensed regulatory system for adults to legally access psychedelics to take on their own without...”
Base rateThe probability a published external study gives an event of that class and stage, fixed at intake. Halved when the item window is shorter than the class median time to decision. Never learned from the ledger's own items. Method ›
None in the table
Tags
retrospective
Coder BCohen's kappa: agreement between two coders beyond chance, from -1 to 1. Reported for admit, event, deadline, bin and asserts from the second-coder match test. Method ›
not admittedA statement that failed intake for a logged reason code. Listed and counted, never scored. Method › (Vague or promotional) · event new · deadline none · bin –
Registry entry

A United States federal or state law, regulation or programme takes effect under which an adult who holds a licence may lawfully buy a psychedelic drug and take it without medical supervision.

TRUE on the effective date of the first federal or state law, regulation or licensed programme in the United States, as published in the Federal Register, a state register or the text of the enacted bill, under which an adult who holds a licence, permit or certificate may lawfully purchase a psychedelic drug (for example psilocybin, MDMA or LSD) and take it on their own, outside medical or facilitator supervision. A programme that requires the dose to be taken under supervision at a licensed service centre, a medical prescription route, a decriminalisation measure that removes penalties without creating a licence to purchase, and a bill that has not taken effect, do not count. FALSE at the deadline when no such law, regulation or programme has taken effect. Resolution source: the Federal Register and state legislature records.

Resolution source: Federal Register; state registers and enacted state legislation (state legislature records)

Readings: 'Licensed legalization' and 'a licensed regulatory system for adults to legally access psychedelics to take on their own' are read as one outcome: a licence that lets an adult buy a psychedelic and take it unsupervised.; 'We' is read as the United States, the jurisdiction the forecaster speaks about in every version of this claim.; A supervised-use service-centre programme does not count, because the forecaster's own words say 'to do on their own' and 'without supervision by therapists'.; 'Access to minors only with permission from their parents or guardians' is a detail of the vision, not part of the criterion.; 'After a decade of clinics' and 'in a post-prohibition world' are the forecaster's reasons, not second conditions.; Psilocybin, MDMA and LSD are the drugs the forecaster names ('A or B' is one event).; The forecaster names no jurisdiction beyond the United States, so the first enacting US jurisdiction, federal or a state, counts; this reading is logged at intake.

How to read
The event, criterion and deadline were written at intake, before the outcome1 if the registry event happened on or before the item's deadline, 0 if it did not. Written by a resolver who never sees p. Method › was looked up. Coder B coded the statement independently.

Coder A

Resolution

State
False
Effective deadlineAn item enters the score only when its deadline has passed and the outcome is true or false. A claim already known true still waits for its deadline. Method ›
13 Dec 2022
Outcome1 if the registry event happened on or before the item's deadline, 0 if it did not. Written by a resolver who never sees p. Method ›
not occurred · checked through 14 Sep 2026
Resolver note
No US federal or state law, rule or licensed programme lets a licence holder buy a psychedelic and take it unsupervised, as of 2026-09-14. The closest development is Colorado HB26-1325, signed 2026-06-04 and effective 2026-08-12, with emergency rules for a Limited Regulated Natural Medicine Sales License. That licence is tied to supervision: the bill widens administration session to cover product the participant buys to consume during the administration session, and healing centers may not sell except through a co-located limited sales licensee. Oregon keeps consumption at a licensed service center with a facilitator. Executive Order 14401 of 2026-04-18 speeds research, investigational access and rescheduling review; it creates no purchase licence. This says nothing about later dates.
BrierThe squared gap between a probability and the outcome, (p - o)^2. 0 is perfect, 0.25 is the constant coin flip, 1 is confidently wrong. Lower is better. Method ›
0.25 = (0.50 − 0)²
How to read
State at window close; the outcome comes from the registry, the score from the rule.

Registry

Receding horizon

Doblin promised A US licence lets adults legally buy psychedelics for unsupervised personal use 2 times; it has not happened.

promised datehappened
20212022202320242025202620272028202920302031203220332034203520362021202220232024202520262027202820292030203120322033203420352036TODAY2020-11-06: by 2035-12-31 · p 0.602020-12-13: by 2022-12-13 · p 0.502021-06-04: by 2035-12-31 · p 0.802021-10-27: by 2035-12-31 · p 0.80X SAID ON · Y PROMISED BY · DASHED: PROMISED = SAID · DOT AREA = P

Cluster E-0134

Timeline

1 claim against 26 events in the field.

saiddueevent
7 Mar 2023 · Sens. Booker and Paul; Reps. Mace and Dean: Breakthrough Therapies Act reintroduced to let DEA move FDA breakthrough-designaSENS. BOOKER AND PAUL; REPS. MACE AND DEAN: BREAKTHROUGH THERAPIES ACT REINTRODUCED TO LET DEA MOVE FDA BREAKTHROUGH-DESIGNA22 Dec 2023 · Congress / President Biden: FY2024 NDAA signed with Section 723: $10M and a DoD process for service members 5 Jan 2024 · Department of Veterans Affairs: VA issues a request for applications to fund research on MDMA, psilocybin and ot26 Mar 2024 · ICER: ICER draft evidence report finds evidence on MDMA-assisted psychotherapy for PTS27 Jun 2024 · ICER: ICER final report: panel votes 14-1 that evidence is inadequate to show net heal23 Sep 2024 · DOL, HHS and Treasury: MHPAEA final rule published (released September 9): NQTL comparative-analysis an3 Dec 2024 · Department of Veterans Affairs: VA awards up to $1.5M over five years for its first VA-funded psychedelic study:9 Dec 2024 · CMS: CY2025 PFS final rule published; CMS keeps telehealth policies under its own aut17 Jan 2025 · ERISA Industry Committee (ERIC): ERIC sues in D.D.C. to vacate parts of the 2024 MHPAEA final rule as arbitrary, 15 May 2025 · DOL, HHS and Treasury: Departments announce they will not enforce the 2024 MHPAEA final rule's new requ11 Jun 2025 · Texas Governor Abbott: Governor signs SB 2308 committing $50M in state matching funds for a consortium 1 Oct 2025 · CMS / Congress: Medicare telehealth flexibilities lapse with the government shutdown; pre-pandem3 Nov 2025 · Department of Veterans Affairs: VA expands psychedelic research to nine VA facilities studying MDMA and psilocyb5 Nov 2025 · CMS: CY2026 PFS final rule published: in-person visit within 12 months required for t12 Nov 2025 · Congress / President Trump: H.R. 5371 signed, ending the shutdown and restoring Medicare telehealth flexibil24 Nov 2025 · Magnus Medical (SAINT): CMS OPPS final rule keeps 2026 hospital outpatient payment stable for SAINT neur4 Dec 2025 · Sens. Booker and Paul; Reps. Dean and Mace: Freedom to Heal Act introduced to require a DEA registration pathway for physici15 Jan 2026 · Texas HHSC: UTHealth Houston-led IMPACT consortium (UTMB, Dell Med, Baylor and others) named5 Feb 2026 · Congress / President Trump: FY2026 appropriations package signed, extending Medicare telehealth flexibilitie30 Mar 2026 · DOL, HHS and Treasury: In an ERIC v. DOL status report, the departments say they will no longer defend 31 Mar 2026 · Texas Lt. Gov. Patrick and Speaker Burrows: Texas announces it will fund the $50M ibogaine trials itself through in-state in30 Jun 2026 · Reps. Luttrell, Correa, Bergman and McCaul: IBOGAINE Act (H.R. 9559) introduced in the House to advance ibogaine research an13 Jul 2026 · VA, HHS and FDA: VA signs memoranda of understanding with HHS and FDA to expand psychedelic trial14 Jul 2026 · HRSA: HRSA issues a request for information on training and care-delivery models for s22 Jul 2026 · U.S. House of Representatives: House passes FY2027 NDAA amendments extending DoD psychedelic clinical trials th7 Aug 2026 · VA Secretary Doug Collins: Collins says ibogaine is the VA's next psychedelic research focus during a SeattA US LICENCE LETS…A US licence lets adults legally buy psychedelics for unsupervised personal use · stated 13 Dec 2020A US licence lets adults legally buy psychedelics for unsupervised personal use · restated 13 Dec 2020 · p 50%A US licence lets adults legally buy psychedelics for unsupervised personal use · miss 13 Dec 202250%TODAY202120222023202420252026

Payer and policy